Uh Oh, We've Lost That Page!
We're sorry...
You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.
New Stories
-
Biotron advances hepatitis B candidate towards human trials after promising HBV and HDV results
August 18, 2026 - - Latest News -
CSL absorbs loss in reset year as investors back its plasma-led recovery
August 18, 2026 - - Latest News -
Mesoblast completes treatment in pivotal low back pain trial as phase 3 readout approaches
August 18, 2026 - - Latest News -
OncoSil secures FDA approval for targeted bile duct cancer device
August 18, 2026 - - Latest News -
Dimerix takes control of US development pathway for new kidney injury treatment
August 18, 2026 - - Latest News -
CUREator+ backs six Australian startups with $13.5 million to advance new health technologies
August 13, 2026 - - Latest News -
QIMR Berghofer heart atlas offers a new path to more precise treatments
August 13, 2026 - - Latest News